NASDAQ: ATRC
AtriCure, Inc.
Healthcare · Medical - Instruments & Supplies
Market Cap
$1.46B
52w High
$43.18
52w Low
$25.36
P/E
-294.48
Volume
1.60M
Outstanding Shares
50.64M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 8.89% over the last year. Revenue grew 15.01% over the trailing twelve months. Operating margin moved from -7.3% to -0.36%.
What the market seems to be pricing
The stock has moved lower against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at -0.36%. A decisive move in revenue — currently up 15.01% — would be the clearest signal to resolve the ambiguity.
Company profile
AtriCure, Inc. creates, produces, and markets medical devices for the surgical treatment of cardiac tissue and intercostal nerves.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
18
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 4, 2026
Q3 FY26 · EPS est $0.03 · Revenue est $151.84M
View